Last updated on July 2018

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma


Brief description of study

The purpose of the trial is to evaluate the efficacy and safety of two different doses of QVM149 (QVM149 150/50/80 g and QVM149 150/50/160 g via Concept1) over two respective QMF149 doses (QMF149 150/160 g and QMF149 150/320 g via Concept1 in poorly controlled asthmatics as determined by pulmonary function testing and effects on asthma control.

Clinical Study Identifier: NCT02571777

Find a site near you

Start Over

Novartis Investigative Site

Concepcion del Uruguay, Argentina
  Connect »

Novartis Investigative Site

San Miguel de Tucuman, Argentina
  Connect »

Novartis Investigative Site

Annaberg-Buchholz, Germany
  Connect »

Novartis Investigative Site

Frankfurt am Main, Germany
  Connect »

Novartis Investigative Site

Szigetszentmiklos, Hungary
  Connect »

Novartis Investigative Site

Ostrow Wielkopolski, Poland
  Connect »

Novartis Investigative Site

Barnaul, Russian Federation
  Connect »

Novartis Investigative Site

Chelyabinsk, Russian Federation
  Connect »

Novartis Investigative Site

Ivanovo, Russian Federation
  Connect »

Novartis Investigative Site

Kemerovo, Russian Federation
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Nizhny Novgorod, Russian Federation
  Connect »

Novartis Investigative Site

Novosibirsk, Russian Federation
  Connect »

Novartis Investigative Site

Pskov, Russian Federation
  Connect »

Novartis Investigative Site

Pyatigorsk, Russian Federation
  Connect »

Novartis Investigative Site

Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Saratov, Russian Federation
  Connect »

Novartis Investigative Site

Smolensk, Russian Federation
  Connect »

Novartis Investigative Site

St. Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

St.-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Tomsk, Russian Federation
  Connect »

Novartis Investigative Site

Ulyanovsk, Russian Federation
  Connect »

Novartis Investigative Site

Vladikavkaz, Russian Federation
  Connect »

Novartis Investigative Site

Volgograd, Russian Federation
  Connect »

Novartis Investigative Site

Yaroslavl, Russian Federation
  Connect »

Novartis Investigative Site

Liptovsky Mikulas, Slovakia
  Connect »

Novartis Investigative Site

Spisska Nova Ves, Slovakia
  Connect »

Novartis Investigative Site

Kempton Park, South Africa
  Connect »

Novartis Investigative Site

St Austell, United Kingdom
  Connect »

Novartis Investigative Site

Waterlooville, United Kingdom
  Connect »

Novartis Investigative Site

Birkenhead, United Kingdom
  Connect »

Novartis Investigative Site

Rotherham, United Kingdom
  Connect »

Novartis Investigative Site

Kazan, Russian Federation
  Connect »

Novartis Investigative Site

Sestroretsk, Russian Federation
  Connect »

Novartis Investigative Site

Vsevolozhsk, Russian Federation
  Connect »

Novartis Investigative Site

Trois-Rivières, QC Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.